Kincell Bio announces collaboration to advance Moonlight Bio’s lead cell therapy candidate to clinical study

Kincell Bio, a leading US cell therapy CDMO, is excited to announce a partnership with Moonlight Bio, Inc., a Seattle-based biotech company pioneering advanced T cell therapies for solid tumors. In this partnership, Kincell provides CMC development and GMP manufacturing services to advance Moonlight’s lead T cell therapy program into clinic trials.

Kole Roybal is the lead UCSF inventor.

More